Multiple Sclerosis  Madam Chair, there must be diagnosis and treatment of CCSVI and then we can follow the people with the research. I also want to point out that it is simply not fair or consistent with charter values to say that angioplasty correction of diagnosed venous insufficiency

Multiple Sclerosis  Madam Chair, MS societies in Canada and the United States have called their early findings surrounding CCSVI exciting, but they have also said they want more research. We will continue to work with them in terms of providing support to see if this new method is effective or not.

Multiple Sclerosis  Madam Chair, the Sherwood Park MS Community Group in my riding is the largest MS group in the country. On their behalf, I would like to ask the minister how CIHR is mobilizing the research community around CCSVI and MS?

Multiple Sclerosis  Madam Chair, the MS Society made an announcement on June 11 to support further research. The MS Society of Canada and the MS Society in the United States say the following: These new studies are necessary because we don’t yet know whether, or if so how, CCSVI contributes to MS

Multiple Sclerosis  Madam Chair, the minister herself has mentioned that what is occurring is very promising, but I want to ask whether it is not correct to treat MS and the CCSVI in different functions. Where it indicates there are restrictions in a vein, why should people not have the treatment

Multiple Sclerosis   the world, we are getting closer to finding better treatments for MS and hopefully a cure. Scientists are intrigued by the potential links between CCSVI and multiple sclerosis. CIHR welcomes and encourages funding applications from researchers wanting to study this new treatment. We

Subcommittee on Neurological Disease committee   the scientific goal, which is actually generating the science on it, determining who should be treated, and so on, as you collect the data. At the same time, you can treat people with significant disease now. If they have significant CCSVIs demonstrated on an MRV and on a duplex scan

Subcommittee on Neurological Disease committee  During your presentation, you told us that, in your opinion, the only thing left to do was to sub-categorize the CCSVI patients. Could you expand a little more on that? In your view, what needs to be done and how long could a surgery like that take? Finally, why is it important

Subcommittee on Neurological Disease committee  Thank you. Do you have any ethical dilemma in deciding to treat MS patients with CCSVI?

Subcommittee on Neurological Disease committee  . Painless. Life-giving. It gave me back what I lost, and I can't thank them enough for that. I really can't. They're my heroes. I think you should let them be heroes for everybody else. My CCSVI was treated with a balloon angioplasty, a procedure that's done every day of the week

Subcommittee on Neurological Disease committee  , in the United States, a little over a week ago, and she's doing just great. [Applause] My goal today is to actually show you images of jugular veins in people who have CCSVI. The abnormalities that we see are real. You don't need to be a physician to see them. Correction sometimes makes

Subcommittee on Neurological Disease committee  . The second thing is that many of the patients, in my understanding, and I stand to be corrected, have been continued on their regular medical therapies, many of which are being shown to have an effect on relapsing-remitting that is very similar to that being described for CCSVI. So I

Subcommittee on Neurological Disease committee   who are not living it to say that we need more research on this, but obviously with what has transpired here and the urgency, there is a need for us to move forward and do it in conjunction with a research study. This CCSVI, I believe, would also assist in eliminating some

Subcommittee on Neurological Disease committee  There are 47 countries in the world that recognize CCSVI as a true entity. In terms of the science, Dr. Zamboni did a study. He looked at 65 patients and found that many patients with MS had significant venous anomalies. He treated 65 patients and many of them saw significant

Subcommittee on Neurological Disease committee  Do you think it would be fair for every MS patient across this country to be imaged for CCSVI?